As of Jan 18
| -0.24 / -0.70%|
The 6 analysts offering 12-month price forecasts for Arena Pharmaceuticals Inc have a median target of 41.00, with a high estimate of 53.00 and a low estimate of 34.00. The median estimate represents a +20.16% increase from the last price of 34.12.
The current consensus among 7 polled investment analysts is to Buy stock in Arena Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.